CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical, Inc. (“Nalu”), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use ...

All the abstracts contain recent clinical data and insights highlighting the utility of the SPRINT PNS System ... on the effectiveness of peripheral nerve stimulation (PNS) compared to Standard ...

Nalu Medical CEO and president Tom West commented: “This FDA clearance strengthens our mission to make peripheral nerve stimulation therapy appropriate for a broader patient population.

All the abstracts contain recent clinical data and insights highlighting the utility of the SPRINT PNS System in the treatment ... reports on the effectiveness of peripheral nerve stimulation (PNS) ...